Tauroursodeoxycholic acid (TUDCA) has been shown to activate the S1PR2 signaling pathway, thereby enhancing the activity of the insulin-degrading enzyme (IDE) and effectively ameliorating hyperinsulinemia and insulin sensitivity [70]. Here, IDE is linked to hyperinsulinism.